Based on the Nephros Inc stock forecast from 1 analysts, the average analyst target price for Nephros Inc is USD 5.00 over the next 12 months. Nephros Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Nephros Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Nephros Inc’s stock price was USD 1.89. Nephros Inc’s stock price has changed by +1.07% over the past week, +15.96% over the past month and -6.90% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for Nephros Inc
No recent average analyst rating found for Nephros Inc
Company Overview Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Read Less
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate con...Read More
Frequently Asked Questions About Nephros Inc (NEPH) Stock
Based on ratings from 1 analysts Nephros Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on NEPH's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for NEPH is USD 5.00 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 5.
NEPH stock's Price/Earning ratio is 204.00.
Our analysis grades NEPH stock's Price / Earning ratio at F. This means that NEPH stock's Price/Earning ratio is above 89% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this NEPH may be a overvalued for its sector.
The last closing price of NEPH's stock was USD 1.89.
The most recent market capitalization for NEPH is USD 0.02B.
Based on targets from 1 analysts, the average taret price for NEPH is projected at USD 5.00 over the next 12 months.
This means that NEPH's stock price may go up by +164.55% over the next 12 months.
We can't find any ETFs which contains Nephros Inc's stock.
As per our most recent records Nephros Inc has 31 Employees.
Nephros Inc's registered address is 380 Lackawanna Place, South Orange, NJ, United States, 07079.
You can get more information about it from Nephros Inc's website at https://www.nephros.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Nephros Inc (NEPH) Stock
Based on ratings from 1 analysts Nephros Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on NEPH's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for NEPH is USD 5.00 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 5.
NEPH stock's Price/Earning ratio is 204.00.
Our analysis grades NEPH stock's Price / Earning ratio at F. This means that NEPH stock's Price/Earning ratio is above 89% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this NEPH may be a overvalued for its sector.
The last closing price of NEPH's stock was USD 1.89.
The most recent market capitalization for NEPH is USD 0.02B.
Based on targets from 1 analysts, the average taret price for NEPH is projected at USD 5.00 over the next 12 months.
This means that NEPH's stock price may go up by +164.55% over the next 12 months.
We can't find any ETFs which contains Nephros Inc's stock.
As per our most recent records Nephros Inc has 31 Employees.
Nephros Inc's registered address is 380 Lackawanna Place, South Orange, NJ, United States, 07079.
You can get more information about it from Nephros Inc's website at https://www.nephros.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NEPH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
